SCHEMBL19082028

SCHEMBL19082028

c1ccc(-c2c3ccccc3c(-c3ccc4cc(-c5cc6sc7c8ccccc8ccc7c6c6oc7ccccc7c56)ccc4c3)c3ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 8/20 0.36
CYP1B1 Q16678 7/20 0.36
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP1A2 P05177 7/20 0.32
ABCG2 Q9UNQ0 2/20 0.32
MAPK1 P28482 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 2/20 0.32
TSHR P16473 2/20 0.32
HSD17B10 Q99714 2/20 0.32
GPR84 Q9NQS5 1/20 0.32
PDE5A O76074 1/20 0.32
TP53 P04637 1/20 0.32
ABCB1 P08183 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081969 0.95 CYP1A1 (0.36) CYP1A1CYP1B1TDP1L3MBTL1CYP1A2
SCHEMBL19081994 0.89 CYP1A1 (0.38) CYP1A1CYP1B1TDP1L3MBTL1CYP1A2
SCHEMBL19082007 0.88 CYP1A1 (0.37) CYP1A1CYP1B1TDP1L3MBTL1CYP1A2
SCHEMBL19081634 0.84 CYP1A1 (0.41) CYP1A1CYP1B1TDP1L3MBTL1CYP1A2
SCHEMBL19082030 0.83 ESR1 (0.32) CYP1A2MAPK1CYP2C9CYP2C19KDM4E
SCHEMBL19080317 0.83 CYP1A1 (0.43) CYP1A1CYP1B1CYP1A2CYP2C9CYP2C19
SCHEMBL19076808 0.83 ALOX5 (0.37) GPR84PRKDCS1PR4S1PR5ALOX5
SCHEMBL19081990 0.82 TDP1 (0.33) CYP1A1CYP1B1TDP1L3MBTL1CYP1A2
SCHEMBL19082347 0.82 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2GPR84S1PR4
SCHEMBL19081970 0.82 CYP1A1 (0.36) CYP1A1CYP1B1TDP1L3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885TDP1 2322/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885TDP1 2322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.